Assessment of Endothelial Function, Apolipoproteins and Adiponectin
NCT01300390 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2016-05-17
Summary
The overall hypothesis is that endothelial function, apolipoprotein levels and adiponectin levels are accurate predictors of underlying cardiovascular disease in patients with end-stage liver disease, in whom standard tools for the diagnosis of and screening for cardiovascular disease are of limited utility.
Conditions
- Cirrhosis
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kymberly Watt, MD · Mayo Clinic
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Liver Health and Metabolic Function in People With Obesity
NCT03701828 ·Status: COMPLETED ·Phase: NA
-
EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases
NCT06392828 ·Status: COMPLETED
-
Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
NCT06932289 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT02812797 ·Status: COMPLETED
-
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study
NCT03534908 ·Status: UNKNOWN
-
Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins
NCT00001226 ·Status: COMPLETED
-
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
NCT02520609 ·Status: COMPLETED
-
Effects of Dietary Nutrients on Liver and Adipose Tissue Metabolism
NCT03090347 ·Status: UNKNOWN ·Phase: NA
-
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
NCT03674528 ·Status: COMPLETED
-
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
NCT04059029 ·Status: UNKNOWN
-
Body Composition and Very-Low-Density-Lipoprotein-Triglycerides (VLDL-TG) Kinetics
NCT00646698 ·Status: COMPLETED
-
De Novo Lipogenesis in Severity of NAFLD
NCT03683589 ·Status: COMPLETED
-
Body Weight and Vascular Function
NCT01675401 ·Status: COMPLETED ·Phase: NA
-
Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients
NCT04462081 ·Status: COMPLETED
-
Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
NCT04209816 ·Status: ENROLLING_BY_INVITATION
-
Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis
NCT01282892 ·Status: UNKNOWN
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Lifestyle, Adiposity and Cardiovascular Health in Youths
NCT00006402 ·Status: COMPLETED
-
Aging, Exercise, and Hormonal Influences of Fat Metabolism
NCT00100451 ·Status: COMPLETED ·Phase: NA
-
The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
NCT01834300 ·Status: COMPLETED ·Phase: NA
-
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
NCT00001154 ·Status: COMPLETED
-
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00983463 ·Status: ENROLLING_BY_INVITATION
-
Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver
NCT02669316 ·Status: COMPLETED
-
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
NCT06009250 ·Status: UNKNOWN
-
Evaluation of Systemic Microvascular Endothelial Function in Metabolically Healthy Obesity
NCT04233528 ·Status: COMPLETED ·Phase: NA